Top 8 Benefits Of Mass Spectrometry Imaging Early In Drug Development

Mass spectrometry imaging (MSI) offers a precise and detailed look into a drug’s biological distribution and its metabolites. This establishes the pharmacokinetic-pharmacodynamic relationship and potential toxicity. MSI is beneficial in early development and murine models across many therapeutic areas, as it has become a an valuable tool for improving the body of scientific evidence available to justify drug advancement into human trials. Here we explore the top 8 benefits in oncology drug discovery and development.